These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 15667140

  • 1. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM, Frühwirth KH, Langer T.
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [Abstract] [Full Text] [Related]

  • 2. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM, Haupt S, Stuppner H, Langer T.
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [Abstract] [Full Text] [Related]

  • 3. Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors.
    Barreca ML, De Luca L, Iraci N, Rao A, Ferro S, Maga G, Chimirri A.
    J Chem Inf Model; 2007; 47(2):557-62. PubMed ID: 17274611
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
    Yu H, Wang Z, Zhang L, Zhang J, Huang Q.
    Bioorg Med Chem Lett; 2007 Apr 15; 17(8):2126-33. PubMed ID: 17306530
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
    Kim J, Kim KS, Kim DE, Chong Y.
    Chem Biol Drug Des; 2008 Dec 15; 72(6):585-91. PubMed ID: 19090925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S, Schneider G.
    J Med Chem; 2004 Sep 09; 47(19):4653-64. PubMed ID: 15341481
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y.
    J Chem Inf Model; 2005 Sep 09; 45(4):1082-100. PubMed ID: 16045304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM, Ridderström M, Luthman K, Zamora I.
    J Chem Inf Model; 2005 Sep 09; 45(5):1313-23. PubMed ID: 16180908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
    Franke L, Schwarz O, Müller-Kuhrt L, Hoernig C, Fischer L, George S, Tanrikulu Y, Schneider P, Werz O, Steinhilber D, Schneider G.
    J Med Chem; 2007 May 31; 50(11):2640-6. PubMed ID: 17461565
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.